i
Preventing cervical cancer in the 21st century
-
January 15, 2019
-
Details:
-
Personal Author:
-
Corporate Authors:Centers for Disease Control and Prevention (U.S,). Office of the Associate Director for Science. ; Centers for Disease Control and Prevention (U.S,). Office of the Associate Director for Communication. ; National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Cancer Prevention and Control. ; National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division.
-
Description:Presented on Tuesday, January 15, 2019.
Each year more than 4,000 U.S. women die from cervical cancer, the 4th most common cancer in women worldwide. Over 90% of cases of cervical cancer are associated with human papillomavirus (HPV) and the risk of cancer varies among the different HPV strains. Fortunately, cervical cancer can be prevented through HPV vaccination and screening, which include Papanicolaou (Pap) and HPV DNA tests. These tests detect abnormal cells before they become cancerous (pre-cancers). If cancer develops, treatment can start early, when it is most effective.
In fact, the combination of screening and HPV vaccination could prevent up to 93% of cervical cancers. Still, gaps remain. Women at the highest risk are often not screened and HPV vaccination rates among U.S. adolescents remain low.
Please watch this session of Public Health Grand Rounds to learn about advances in screening and vaccination efforts and what can be done by communities across the country.
Presented by: Mona Saraiya, MD, MPH, CAPT, USPHS, Team Lead, Health Services Research Team, Division of Cancer Prevention and Control ["Cervical Cancer Control in the 21st Century"]; Melinda Wharton, MD, MPH, Director, Immunization Services Division, National Center for Immunization and Respiratory Diseases ["HPV Vaccines Are Key to Preventing Future Cervical Cancer"]; Nicolas Wentzensen, MD, PhD, MS, Deputy Branch Chief and Senior Investigator, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH ["Novel Tools for Screening in High- and Low-Resource Settings"]; Francisco Garcia, MD, MPH, Assistant County Administrator and Chief Medical Officer, Pima County Department of Health, Tucson, Arizona, ["Local Perspective: The Challenges of Cervical Cancer Prevention in Border Counties"]; Lisa C. Richardson, MD MPH, Director, Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion ["Role of Healthcare Providers in Cervical Cancer Prevention: Now and in the Future"].
Facilitated by: John Iskander, MD, MPH, Scientific Director, Public Health Grand Rounds; Phoebe Thorpe, MD, MPH, Deputy Scientific Director, Public Health Grand Rounds; Susan Laird, MSN, RN, Communications Director, Public Health Grand Rounds.
Includes video interview between Phoebe Thorpe and Franciso Garcia: Beyond the Data - Preventing Cervical Cancer in the 21st Century
20190125-presentation-cervical-cancer-H.pdf
-
Content Notes:Cervical Cancer Control in the 21st Century [PDF version of the PowerPoint presentation by Mona Saraiya, p. 5-18] – HPV Vaccination in the United States: Current Status [PDF version of the PowerPoint presentation by Nina Brown-Ashford, p. 19-30] -- Novel Tools for Screening in High- and Low-Resource Settings [PDF version of the PowerPoint presentation by Nicolas Wentzensen, p. 31-60] -- Cervical Cancer Prevention in Border Counties [PDF version of the PowerPoint presentation by Francisco Garcia, p. 42-60] – Role of Healthcare Providers in Cervical Cancer Prevention: Now and in the Future [PDF version of the PowerPoint presentation by Lisa C. Richardson, p. 61-64].
-
Subjects:
-
Series:
-
Document Type:
-
Genre:
-
Place as Subject:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: